4,580
Views
48
CrossRef citations to date
0
Altmetric
Reviews

Laser and radiofrequency ablations for benign and malignant thyroid tumors

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 13-20 | Received 03 May 2019, Accepted 20 May 2019, Published online: 20 Sep 2019

References

  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
  • Shin JH, Baek JH, Chung J, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean society of thyroid radiology consensus statement and recommendations. Korean J Radiol. 2016;17:370–395.
  • Kim J-H, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19:632–655.
  • Mauri G, Nicosia L, Della Vigna P, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38:25–36.
  • Hahn SY, Shin JH, Na DG, et al. Ethanol ablation of the thyroid nodules: 2018 consensus statement by the Korean society of thyroid radiology. Korean J Radiol. 2019;20:609–620.
  • Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia. 2019;36:1–7.
  • Kim J-H, Baek JH, Lim HK, et al. Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline. Ultrasonography. 2019;38:125–134.
  • Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29:611–618.
  • Papini E, Bizzarri G, Pacella CM. Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2008;15:434–439.
  • Mauri G, Cova L, Monaco CG, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia. 2017;33:295–299.
  • Pescatori LC, Torcia P, Nicosia L, et al. Which needle in the treatment of thyroid nodules? Gland Surg. 2018;7:111–116.
  • Achille G, Zizzi S, Di Stasio E, et al. Ultrasound-guided percutaneous laser ablation in treating symptomatic solid benign thyroid nodules: our experience in 45 patients. Head Neck. 2016;38:677–682.
  • Mauri G, Cova L, Tondolo T, et al. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J Clin Endocrinol Metab. 2013;98:E1203–E1207.
  • Zhang L, Zhou W, Zhan W. Role of ultrasound in the assessment of percutaneous laser ablation of cervical metastatic lymph nodes from thyroid carcinoma. Acta Radiol. 2018;59:434–440.
  • Baek JH, Lee JH, Valcavi R, et al. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011;12:525–540.
  • Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017;18:615–623.
  • Chung SR, Baek JH, Choi YJ, et al. Management strategy for nerve damage during radiofrequency ablation of thyroid nodules. Int J Hyperthermia. 2019;36:204–210.
  • Dietrich CF, Müller T, Bojunga J, et al. Statement and recommendations on interventional ultrasound as a thyroid diagnostic and treatment procedure. Ultrasound Med Biol. 2018;44:14–36.
  • Papini E, Guglielmi R, Bizzarri G, et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid. 2007;17:229–235.
  • Papini E, Rago T, Gambelunghe G, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab. 2014;99:3653–3659.
  • Pacella CM, Mauri G, Achille G, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100:3903–3910.
  • Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20:11–22.
  • Sui WF, Li JY, Fu JH. Percutaneous laser ablation for benign thyroid nodules: a meta-analysis. Oncotarget. 2017;8:83225–83236.
  • Pacella CM, Mauri G, Cesareo R, et al. A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis. Int J Hyperthermia. 2017;33:911–919.
  • Døssing H, Bennedbaek FN, Hegedüs L. Ultrasound-guided interstitial laser photocoagulation of an autonomous thyroid nodule: the introduction of a novel alternative. Thyroid. 2003;13:885–888.
  • Spiezia S, Vitale G, Di Somma C, et al. Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid. 2003;13:941–947.
  • Døssing H, Bennedbaek FN, Bonnema SJ, et al. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007;157:95–100.
  • Barbaro D, Orsini P, Lapi P, et al. Percutaneous laser ablation in the treatment of toxic and pretoxic nodular goiter. Endocr Pract. 2007;13:30–36.
  • Valcavi R, Piana S, Bortolan GS, et al. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid. 2013;23:1578–1582.
  • Gambelunghe G, Stefanetti E, Colella R, et al. A single session of laser ablation for toxic thyroid nodules: three-year follow-up results. Int J Hyperthermia. 2018;34:631–635.
  • Negro R, Greco G. Quality of life and outcomes in patients with a large toxic adenoma undergoing laser ablation plus radioiodine vs. lobectomy. Int J Hyperthermia. 2019;36:191–195.
  • Chianelli M, Bizzarri G, Todino V, et al. Laser ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter. J Clin Endocrinol Metab. 2014;99:E1283–E1286.
  • Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18:1244–1250.
  • Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23:1044–1049.
  • Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19:167–174.
  • Bernardi S, Dobrinja C, Fabris B, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595.
  • Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. Am J Neuroradiol. 2015;36:1321–1325.
  • Cesareo R, Naciu AM, Iozzino M, et al. Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. Int J Hyperthermia. 2018;34:617–623.
  • Bernardi S, Stacul F, Michelli A, et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine 2017;57:402–408.
  • Baek JH, Moon W-J, Kim YS, et al. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg. 2009;33:1971–1977.
  • Kim C, Lee JH, Choi YJ, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol. 2017;27:3128–3137.
  • Baek JH, Lee JH, Sung JY, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262:335–342.
  • Wang J-F, Wu T, Hu K-P, et al. Complications following radiofrequency ablation of benign thyroid nodules: a systematic review. Chin Med. 2017;130:1361–1370.
  • Haser GC, Tuttle RM, Su HK, et al. Active surveillance for papillary thyroid microcarcinoma: new challenges and opportunities for the health care system. Endocr Pract. 2016;22:602–611.
  • Iñiguez-Ariza NM, Brito JP. Management of low-risk papillary thyroid cancer. Endocrinol Metab. 2018;33:185–194.
  • Mauri G, Sconfienza LM. Image-guided thermal ablation might be a way to compensate for image deriving cancer overdiagnosis. Int J Hyperthermia. 2017;33:489–490.
  • Pacella CM, Bizzarri G, Spiezia S, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004;232:272–280.
  • Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011;21:917–920.
  • Lee J, Jung JH, Kim WW, et al. Ultrasound-guided laser ablation using multidirectional-firing fiber for papillary thyroid carcinoma: an ex vivo study with evaluation of tumor cell viability. Photomed Laser Surg. 2016;34:300–304.
  • Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42:2476–2484.
  • Papini E, Bizzarri G, Bianchini A, et al. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab. 2013;98:E92–E97.
  • Zhou W, Zhang L, Zhan W, et al. Percutaneous laser ablation for treatment of locally recurrent papillary thyroid carcinoma <15 mm. Clin Radiol. 2016;71:1233–1239.
  • Ji L, Wu Q, Gu J, et al. Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients. Cancer Imaging. 2019;19:16.
  • Zhou W, Jiang S, Zhan W, et al. Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results. Eur Radiol. 2017;27:2934–2940.
  • Suh CH, Baek JH, Choi YJ, et al. Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis. Thyroid. 2016;26:420–428.
  • Chung SR, Baek JH, Choi YJ, et al. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer. Eur Radiol. 2019;1–7. DOI:10.1007/s00330-019-06063-5.
  • Kim J, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276:909–918.
  • Choi Y, Jung SL, Bae J-S, et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study. Int J Hyperthermia. 2019;36:359–367.
  • Jeong SY, Baek JH, Choi YJ, et al. Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma. Int J Hyperthermia. 2018;34:611–616.
  • Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26:1581–1587.
  • Kim J-H, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroid carcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia. 2017;33:212–219.
  • Jeong SY, Baek JH, Choi YJ, et al. Ethanol and thermal ablation for malignant thyroid tumours. Int J Hyperthermia. 2017;33:938–945.